References

  1. Schorb E, Finke J, Ferreri AJ, Ihorst G, Mikesch K, Kasenda B et al. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma-a randomized phase III trial (MATRix). BMC Cancer. 2016 Apr 21; 16: 282. PubMed | Google Scholar

  2. Sebastián C, Vela AC, Figueroa R, Marín MÁ, Alfaro J. Primary Intracranial Mucosa-Associated Lymphoid Tissue Lymphoma: a report of two cases and literature review. The neuroradiology journal. 2014; 27(4): 425-30. PubMed | Google Scholar

  3. Gilani A, Shafique K, Iordanou J, Sadr A, Shao C, Liu J. Intracranial Dural Marginal Zone Lymphoma: a case report. Clin Oncol. 2016; 1: 1145. Google Scholar

  4. Gouveia GR, Siqueira SAC, Pereira J. Pathophysiology and molecular aspects of diffuse large B-cell lymphoma. Rev Bras Hematol Hemoter. 2012; 34(6): 447-51. PubMed | Google Scholar

  5. Ueba T, Okawa M, Abe H, Inoue T, Takano K, Hayashi H et al. Central nervous system marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type involving the brain and spinal cord parenchyma. Neuropathology. 2013; 33(3): 306-11. PubMed | Google Scholar

  6. Kulkarni KM, Sternau L, Dubovy SR, Lam BL. Primary dural lymphoma masquerading as a meningioma. Journal of Neuro-Ophthalmology. 2012; 32(3): 240-2. PubMed | Google Scholar

  7. Tandon R, Mukherjee U, Abrari A, Patir R, Tandon A, Bansal B. Primary dural follicular lymphoma masquerading a meningioma: a case report. British journal of neurosurgery. 2012; 26(6): 905-6. PubMed | Google Scholar

  8. Norris D, Stone J. WHO classification of tumours of haematopoietic and lymphoid tissues. 2008. Google Scholar

  9. dos Santos Guilherme R, Caputto LZ, Fonseca ALA, Pereira J, Fonseca FLA. Exames laboratoriais complementares indicados no apoio ao diagnóstico do Linfoma Difuso de Grandes Células B (LDGCB). Arquivos Brasileiros de Ciências da Saúde. 2008; 33(3). Google Scholar

  10. Iwamoto FM, DeAngelis LM, Abrey LE. Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology. 2006; 66(11): 1763-5. PubMed | Google Scholar

  11. Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'neill BP et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. Journal of Clinical Oncology. 2005; 23(24): 5718-27. PubMed | Google Scholar

  12. Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Central nervous system manifestations of marginal zone B-cell lymphoma. Annals of hematology. 2010; 89(10): 1003-9. PubMed | Google Scholar

  13. Park I, Huh J, Kim JH, Lee S-w, Ryu M-H, Kang Y-K. Primary central nervous system marginal zone B-cell lymphoma of the Basal Ganglia mimicking low-grade glioma: a case report and review of the literature. Clinical Lymphoma and Myeloma. 2008; 8(5): 305-8. PubMed | Google Scholar

  14. Kelley TW, Prayson RA, Barnett GH, Stevens GH, Cook JR, Hsi ED. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricle. Leukemia & lymphoma. 2005; 46(10): 1423-7. PubMed | Google Scholar

  15. Jung TY, Jung S, Lee MC, Lee KH. Extranodal marginal zone B-cell lymphoma mimicking meningioma in lateral ventricle: a case report and possible pathogenesis. Journal of neuro-oncology. 2006; 80(1): 63-7. PubMed | Google Scholar

  16. Carnevale J, Rubenstein JL. The challenge of primary central nervous system lymphoma. Hematology/Oncology Clinics. 2016; 30(6): 1293-316. PubMed | Google Scholar

  17. Sanjeevi A, Krishnan J, Bailey PR, Catlett J. Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus. Leukemia & lymphoma. 2001; 42(5): 1133-7. PubMed | Google Scholar

  18. Lehman NL, Horoupian DS, Warnke RA, Sundram UN, Peterson K, Harsh IV GR. Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma: case report. Journal of neurosurgery. 2002; 96(2): 368-72. PubMed | Google Scholar

  19. Garcia-Serra A, Price Mendenhall N, Hinerman RW, Lynch JW, Braylan RC, Mancuso AA. Management of neurotropic low-grade B-cell lymphoma: Report of two cases. Head & neck. 2003; 25(11): 972-6. PubMed | Google Scholar

  20. Herrlinger U, Schäfer N, Fimmers R, Griesinger F, Rauch M, Kirchen H et al. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. Journal of Cancer Research and Clinical Oncology. 2017; 143(9): 1815-21. PubMed | Google Scholar

  21. DeFilipp Z, Li S, El-Jawahri A, Armand P, Nayak L, Wang N et al. High-dose chemotherapy with thiotepa, busulfan and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission. Cancer. 2017 Aug 15; 123(16): 3073-3079. PubMed | Google Scholar

  22. Beriwal S, Hou JS, Miyamoto C, Garcia-Young JA. Primary dural low grade BCL-2 negative follicular lymphoma: a case report. Journal of Neuro-oncology. 2003; 61(1): 23-5. PubMed | Google Scholar

  23. Riccioni L, Morigi F, Cremonini AM. Follicular lymphoma of the dura associated with meningioma: a case report and review of the literature. Neuropathology. 2007; 27(3): 278-83. PubMed | Google Scholar

  24. Amen F, Horncastle D, Elderfield K, Banham A, Bower M, Macdonald D et al. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients. Histopathology. 2007; 51(1): 70-9. PubMed | Google Scholar

  25. Kramer M, Hermans J, Parker J, Krol A, Kluin-Nelemans J, Haak H et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. Journal of Clinical Oncology. 1996; 14(7): 2131-8. PubMed | Google Scholar

  26. Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. Journal of Clinical Oncology. 2005; 23(26): 6351-7. PubMed | Google Scholar

  27. Schneider C, Pasqualucci L, Dalla-Favera R, editors. Molecular pathogenesis of diffuse large B-cell lymphoma: seminars in diagnostic pathology. Elsevier. 2011; 28(2): 167-177. Google Scholar

  28. Júnior GBC, Klumb CE, Maia RC. p53 e as hemopatias malignas. Revista Brasileira de Cancerologia. 2002; 48(3): 419-27. Google Scholar